(Q39134353)

English

S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab

scientific article published on 26 June 2013

In more languages
default for all languages
No label defined

No description defined

Statements

S49076 is a novel kinase inhibitor of MET, AXL, and FGFR with strong preclinical activity alone and in association with bevacizumab (English)
Mike F Burbridge
Céline J Bossard
Stéphane Léonce
Georges Da Violante
François Bouzom
Valérie Cattan
Anne Jacquet-Bescond
Brian P Lockhart
Jean-Claude Ortuno
Francisco H Cruzalegui
Stéphane Depil

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit